135 related articles for article (PubMed ID: 22122704)
21. CpG island methylator phenotypes in aging and cancer.
Toyota M; Issa JP
Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation and hepatocellular carcinoma.
Zhu J
J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
[TBL] [Abstract][Full Text] [Related]
23. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers.
Kim JG; Takeshima H; Niwa T; Rehnberg E; Shigematsu Y; Yoda Y; Yamashita S; Kushima R; Maekita T; Ichinose M; Katai H; Park WS; Hong YS; Park CH; Ushijima T
Cancer Lett; 2013 Mar; 330(1):33-40. PubMed ID: 23196062
[TBL] [Abstract][Full Text] [Related]
25. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
26. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
Savio AJ; Bapat B
Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
[TBL] [Abstract][Full Text] [Related]
27. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
28. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
[TBL] [Abstract][Full Text] [Related]
29. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
Cai GX; Xu Y; Cai SJ; Shi YQ; Lian P; Peng JJ; Guan ZQ; Du X
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):555-60. PubMed ID: 18000779
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation changes in cancer.
Toyota M; Yamamoto E
Prog Mol Biol Transl Sci; 2011; 101():447-57. PubMed ID: 21507361
[TBL] [Abstract][Full Text] [Related]
32. CpG island methylation in colorectal adenomas.
Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR
Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation changes in cervical cancers.
Lu Q; Ma D; Zhao S
Methods Mol Biol; 2012; 863():155-76. PubMed ID: 22359292
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
35. [Colorectal carcinogenesis. 2. Underlying epigenetic and genetic alterations and molecular classification of colorectal cancers].
Karoui M; Tresallet C; Brouquet A; Radvanyi H; Penna C
J Chir (Paris); 2007; 144(2):97-104. PubMed ID: 17607223
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
Laczmanska I; Sasiadek MM
Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and epigenetic instability in human hepatocarcinogenesis.
Nishida N; Kudo M
Dig Dis; 2013; 31(5-6):447-53. PubMed ID: 24281019
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal cancer (CCR): genetic and molecular alterations].
Juárez-Vázquez CI; Rosales-Reynoso MA
Gac Med Mex; 2014; 150(2):154-64. PubMed ID: 24603996
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathways and cellular metabolism in colorectal cancer.
Hagland HR; Berg M; Jolma IW; Carlsen A; Søreide K
Dig Surg; 2013; 30(1):12-25. PubMed ID: 23595116
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of CpG island methylator phenotype-positive colorectal cancers: role of genetic alteration and colonic flora.
Tahara T; Arisawa T
Epigenomics; 2014 Jun; 6(3):249-51. PubMed ID: 25111477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
